Patents for C07K 19 - Hybrid peptides (29,428) |
---|
04/15/1998 | EP0650367A4 Blocking intercellular interactions with cd43 chimeric molecules. |
04/15/1998 | CN1179181A GnRH-leukotoxin chimeras |
04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
04/14/1998 | US5739307 Cell growth factors |
04/14/1998 | US5739292 HCMV/HSV fusion glycoproteins |
04/14/1998 | US5739291 Glutamate receptor antibodies |
04/14/1998 | US5738849 Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
04/14/1998 | US5738844 Polypeptides |
04/09/1998 | WO1998014605A1 Renilla luciferase and green fluorescent protein fusion genes |
04/09/1998 | WO1998014584A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
04/09/1998 | WO1998014581A1 Mammalian chemokines |
04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
04/09/1998 | WO1998014475A1 Vertebrate smoothened proteins |
04/09/1998 | WO1998000546A3 Bacillus thuringiensis toxins active against noctuidae pests |
04/09/1998 | WO1997045746A3 Prion protein binding proteins and uses thereof |
04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
04/09/1998 | CA2267181A1 Vertebrate smoothened proteins |
04/09/1998 | CA2267092A1 Mammalian chemokines |
04/08/1998 | EP0833941A1 Polypeptides having a functional domain of interest and methods of identifying and using same |
04/08/1998 | EP0833933A1 A method for producing influenza hemagglutinin multivalent vaccines |
04/08/1998 | EP0833930A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
04/08/1998 | EP0833929A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
04/08/1998 | EP0833909A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines |
04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
04/08/1998 | EP0833658A1 Inhibin compositions and methods of enhancing production performance |
04/07/1998 | US5736361 Production of gonorrheal PI proteins |
04/07/1998 | US5736131 Hybrid toxin |
04/02/1998 | WO1998013513A2 Methods and compositions for identifying receptor effectors |
04/02/1998 | WO1998012910A2 NOVEL CREBa ISOFORM |
04/02/1998 | WO1998002454A3 Conjugates of soluble peptidic compounds with membrane-binding agents |
04/02/1998 | CA2236154A1 Novel creba isoform |
04/02/1998 | CA2213257A1 Oligopeptide derivatives |
04/01/1998 | EP0832236A1 Methods for enhancement of protective immune responses |
04/01/1998 | EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells |
04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
04/01/1998 | EP0832199A1 Fucosyltransferase genes and uses thereof |
04/01/1998 | EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
04/01/1998 | EP0832134A1 Anti-allergy bispecific molecules |
04/01/1998 | EP0832106A2 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity |
04/01/1998 | EP0832093A1 Expression of lipoproteins |
04/01/1998 | CN1177982A System for the expression of heterologous antigens as fusion proteins |
03/31/1998 | US5734035 Nematode vaccine |
03/31/1998 | US5733548 Stimulating t-cell response |
03/31/1998 | US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts |
03/26/1998 | WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/26/1998 | WO1997048724A3 Human metabotropic glutamate receptor |
03/26/1998 | WO1997040063A3 Pathogenic escherichia coli associated protein espa |
03/26/1998 | CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/25/1998 | EP0830601A1 Use of a phycobiliprotein-binding peptide complex as a fluorescent tracer |
03/25/1998 | EP0679094B1 Compounds for targeting |
03/25/1998 | EP0564531B1 Enrichment method for variant proteins with altered binding properties |
03/25/1998 | EP0461165B2 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
03/25/1998 | CN1037844C Tnf-muteins |
03/24/1998 | US5731415 Lipopolysaccharide binding protein derivatives |
03/24/1998 | US5731170 DNA encoding a growth factor specific for epithelial cells |
03/24/1998 | US5731168 Method for making heteromultimeric polypeptides |
03/24/1998 | US5730984 Vaccine against helminth infection comprising Sm-14 fatty acid binding protein of Schistosoma mansoni |
03/24/1998 | US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof |
03/24/1998 | CA1339773C Derivative of adult t cell leukemia virus antigen peptide |
03/19/1998 | WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY |
03/19/1998 | WO1998011134A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
03/19/1998 | CA2264964A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
03/18/1998 | EP0828843A1 Recombinant heregulins and their biological functions upon receptor activation |
03/18/1998 | EP0828842A1 Novel fusion protein recovery and purification methods |
03/18/1998 | EP0828829A1 A gene switch comprising an ecdysone receptor |
03/18/1998 | EP0828758A1 Chimeric fatty body-pro-grf analogs with increased biological potency |
03/18/1998 | CN1176659A A method for making heteromultimeric polypeptides |
03/18/1998 | CN1176658A Vaccine and antitoxin for treatment and prevention of C. difficile disease |
03/17/1998 | US5728813 Antibodies directed against elk ligand |
03/17/1998 | US5728679 BMP-15 compositions |
03/17/1998 | US5728677 Administering a specified polypeptide to a mammal |
03/17/1998 | US5728578 Peptide of the structural phosphoprotein (pp 150) of human cytomegalovirus, and DNA encoding said peptide |
03/17/1998 | US5728387 Structural gene of pneumococcal protein |
03/17/1998 | CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice |
03/17/1998 | CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection |
03/12/1998 | WO1997046259A3 Chimeric toxin for targeted therapy |
03/11/1998 | EP0827544A2 Multimeric proteins |
03/10/1998 | US5726290 Soluble analogues of integrins |
03/10/1998 | US5726037 Host cells and method of producing soluble analogues of integrins |
03/10/1998 | US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
03/10/1998 | US5726035 Recombinant production of mammalian calcium channel gamma subunits |
03/10/1998 | US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein |
03/10/1998 | CA1339709C Monoclonal antibodies to human pancreatic cancer |
03/05/1998 | WO1998008957A1 Compositions and methods for specifically targeting tumors |
03/05/1998 | WO1998008949A1 P-selectin ligand proteins |
03/05/1998 | WO1998008945A1 Protein inhibitor of neuronal nitric oxide synthase |
03/05/1998 | WO1998008933A1 Kuz, a novel family of metalloproteases |
03/05/1998 | WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
03/05/1998 | CA2264576A1 Protein inhibitor of neuronal nitric oxide synthase |
03/05/1998 | CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
03/04/1998 | EP0826060A2 Embedded expression of heterologous proteins |
03/04/1998 | EP0826058A2 Chimeric mcp and daf proteins with cell surface localizing domain |
03/04/1998 | EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
03/04/1998 | EP0826044A1 Bmp-15 compositions |
03/04/1998 | EP0826038A2 Soluble, active hepatitis c virus protease |
03/04/1998 | EP0390799B1 Respiratory syncytial virus: vaccines |
03/03/1998 | US5723313 ARF-p19, a novel regulator of the mammalian cell cycle |